Ascensia Diabetes Care Revenue and Competitors

Parsippany, NJ USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Ascensia Diabetes Care's estimated annual revenue is currently $422.9M per year.(i)
  • Ascensia Diabetes Care's estimated revenue per employee is $251,000

Employee Data

  • Ascensia Diabetes Care has 1685 Employees.(i)
  • Ascensia Diabetes Care grew their employee count by 0% last year.

Ascensia Diabetes Care's People

NameTitleEmail/Phone
1
Head Pre-Market Regulatory AffairsReveal Email/Phone
2
Head Corporate Communications, Ascensia Diabetes CareReveal Email/Phone
3
Head Trade SalesReveal Email/Phone
4
Head Market Access, BGMReveal Email/Phone
5
Head Market DevelopmentReveal Email/Phone
6
VP OperationsReveal Email/Phone
7
VP, Global CGM & Commercial OperationsReveal Email/Phone
8
Head Corporate TaxReveal Email/Phone
9
Head Finance Systems & ProcessesReveal Email/Phone
10
Head End User ComputingReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7.8M3111%N/AN/A
#2
$12.3M49-4%N/AN/A
#3
$15.1M607%N/AN/A
#4
$8.8M35-8%N/AN/A
#5
$3M129%N/AN/A
#6
$300.4M11973%N/AN/A
#7
$311.7M12422%N/AN/A
#8
$0.3M1-96%N/AN/A
#9
$8.3M333%N/AN/A
#10
$13.6M548%N/AN/A
Add Company

What Is Ascensia Diabetes Care?

Ascensia Diabetes Care is a global company dedicated to improving the lives of people with diabetes and helping empower them to take charge of their health and happiness. Our goal is to provide products and solutions that make a positive, daily difference for people with diabetes. We want to help make sure diabetes doesn’t get in the way of people’s future, enabling them to live richer lives.

keywords:N/A

N/A

Total Funding

1685

Number of Employees

$422.9M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Ascensia Diabetes Care News

2022-04-19 - Digital Diabetes Management Market worth $25.5 billion by ...

Browse in-depth TOC on "Digital Diabetes Management Market" ... Tandem Diabetes Care (US), Ascensia Diabetes Care Holdings AG (Switzerland),...

2022-04-06 - Senseonics announces first Eversense E3 CGM implant in US

Senseonics Eversense E3 Ascensia Diabetes Care The Eversense E3 system. [Image from Ascensia/Senseonics] Senseonics (NYSE:SENS) announced...

2022-03-30 - Ascensia Diabetes Care launches Eversense's 6-month CGM ...

Through a commercialization partnership with Ascensia Diabetes Care, which serves as the exclusive worldwide distributor of Senseonics'...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$272.4M19463%N/A
#2
$1968.4M43805%N/A
#3
$1716.1M482631%N/A
#4
$300M67445%N/A
#5
$1892.7M90136%N/A